129 related articles for article (PubMed ID: 33438725)
1. Computational analysis of Cyclin D1 gene SNPs and association with breast cancer.
Aftab A; Khan R; Shah W; Azhar M; Unar A; Jafar Hussain HM; Waqas A
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33438725
[TBL] [Abstract][Full Text] [Related]
2. BRCA2 Polymorphisms and Breast Cancer Susceptibility: a Multi-Tools Bioinformatics Approach.
Jan H; Khan NU; Al-Qaaneh AM; Tasleem M; Almutairi MH; Ali I
Cell Physiol Biochem; 2024 Mar; 58(2):128-143. PubMed ID: 38623065
[TBL] [Abstract][Full Text] [Related]
3. Predicting the most deleterious missense nsSNPs of the protein isoforms of the human HLA-G gene and in silico evaluation of their structural and functional consequences.
Emadi E; Akhoundi F; Kalantar SM; Emadi-Baygi M
BMC Genet; 2020 Aug; 21(1):94. PubMed ID: 32867672
[TBL] [Abstract][Full Text] [Related]
4. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.
Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M-
Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Liu X; Yao W; Xiong H; Li Q; Li Y
Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
[TBL] [Abstract][Full Text] [Related]
6. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
7. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
8. Computational analysis of structural and functional evaluation of the deleterious missense variants in the human
Bouqdayr M; Abbad A; Baba H; Saih A; Wakrim L; Kettani A
J Biomol Struct Dyn; 2023; 41(23):14179-14196. PubMed ID: 36764830
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression.
Hosokawa Y; Arnold A
Genes Chromosomes Cancer; 1998 May; 22(1):66-71. PubMed ID: 9591636
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 gene (CCND1) mutations in endometrial cancer.
Moreno-Bueno G; Rodríguez-Perales S; Sánchez-Estévez C; Hardisson D; Sarrió D; Prat J; Cigudosa JC; Matias-Guiu X; Palacios J
Oncogene; 2003 Sep; 22(38):6115-8. PubMed ID: 12955092
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.
Lanzino M; Sisci D; Morelli C; Garofalo C; Catalano S; Casaburi I; Capparelli C; Giordano C; Giordano F; Maggiolini M; Andò S
Nucleic Acids Res; 2010 Sep; 38(16):5351-65. PubMed ID: 20421209
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation.
Wang J; Su W; Zhang T; Zhang S; Lei H; Ma F; Shi M; Shi W; Xie X; Di C
Cell Death Dis; 2023 Apr; 14(4):244. PubMed ID: 37024471
[TBL] [Abstract][Full Text] [Related]
13. Association of CCND1 Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-Analysis.
Soleimani Z; Kheirkhah D; Sharif MR; Sharif A; Karimian M; Aftabi Y
Pathol Oncol Res; 2017 Jul; 23(3):621-631. PubMed ID: 28004353
[TBL] [Abstract][Full Text] [Related]
14. Performance of mutation pathogenicity prediction methods on missense variants.
Thusberg J; Olatubosun A; Vihinen M
Hum Mutat; 2011 Apr; 32(4):358-68. PubMed ID: 21412949
[TBL] [Abstract][Full Text] [Related]
15. Computational analysis of high-risk SNPs in human CHK2 gene responsible for hereditary breast cancer: A functional and structural impact.
Badgujar NV; Tarapara BV; Shah FD
PLoS One; 2019; 14(8):e0220711. PubMed ID: 31398194
[TBL] [Abstract][Full Text] [Related]
16. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
17. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
18. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
Roy PG; Pratt N; Purdie CA; Baker L; Ashfield A; Quinlan P; Thompson AM
Int J Cancer; 2010 Jul; 127(2):355-60. PubMed ID: 19904758
[TBL] [Abstract][Full Text] [Related]
19. Impacts of Nonsynonymous Single Nucleotide Polymorphisms of Adiponectin Receptor 1 Gene on Corresponding Protein Stability: A Computational Approach.
Saleh MA; Solayman M; Paul S; Saha M; Khalil MI; Gan SH
Biomed Res Int; 2016; 2016():9142190. PubMed ID: 27294143
[TBL] [Abstract][Full Text] [Related]
20. The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours.
Lundberg A; Lindström LS; Li J; Harrell JC; Darai-Ramqvist E; Sifakis EG; Foukakis T; Perou CM; Czene K; Bergh J; Tobin NP
Breast Cancer Res; 2019 Feb; 21(1):34. PubMed ID: 30819233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
